Skip to Content

Lower-risk myelodysplastic syndromes treated with Reblozyl, luspatercept – Real-world outcomes

Sudipto Mukherjee from Cleveland Clinic in Ohio presents in this MEDtalk the results of a retrospective, observational cohort study of adults diagnosed with lower-risk myelodysplastic syndromes and treated with luspatercept.

Sudipto Mukherjee

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top